DIASTOLIC DYSFUNCTION IN HYPERTROPHIC NONOBSTRUCTIVE CARDIOMYOPATHY

Cover Page


Cite item

Full Text

Abstract

Objective: The purpose of research was to assess the availability and prevalence of types of diastolic dysfunction of the left ventricle (LV) in hypertrophic nonobstructive cardiomyopathy (NHCM). Methods: 97 NHCM patients. Mean age 42,5±14,9 years. Diastolic dysfunction assessed by Doppler echocardiography. Results: Signs of chronic heart failure NYHA class I observed in 44 (45%) patients, class II — in 40 (41%), class III — in 13 (13%) patients. 83% patients had LV diastolic dysfunction, mainly on the hypertrophic type. One third of the patients had pseudonormal type with uncertain interpretation. Diastolic dysfunction in terms of clinical manifestations determined mainly NYHA class III and syncope. Severity of LV diastolic dysfunction in NHCM depended on the severity of hypertrophy not only left, but the right ventricle too. In 94% of cases we observed not only diastolic dysfunction, but also reduction of secondary fibers shortening fraction — as sign of contractile dysfunction. Conclusion: Thus, in NHCM dominated diastolic dysfunction of hypertrophic type. Such dysfunction defining a clinic cardiac deficiency or syncope. One third of the patients had pseudonormal transmitral flow type, difficult to assess diastolic function. Diastolic dysfunction in NHCM was combined with impaired contractility of the walls of ventricle.

 

About the authors

D. V. Bogdanov

South Ural State Medical University, Chelyabinsk, Russian Federation

Author for correspondence.
Email: dmitrchel@mail.ru

кандидат медицинских наук, доцент кафедры пропедевтики внутренних болезней ЮУГМУ Адреc: 454007, Челябинск, Артиллерийский пер., 2-79, тел.: +7 (912) 477-34-37

Russian Federation

References

  1. Беленков Ю.Н., Привалова Е.В., Каплунова В.Ю. Гипертрофическая кардиомиопатия. М.: ГЭОТАР-Медиа. 2011. 392.
  2. Gersh B.J., Maron B.J., Bonow R.O., Dearani J.A., Fifer M.A., Link M.S. et al. 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy. Circulation. 2011; 124: 2761–2796.
  3. Беленков Ю.Н., Мареев В.Ю., Агеев Ф.Т. Хроническая сердечная недостаточность. Избранные лекции по кардиологии. М.: ГЭО-ТАР-Медиа. 2006. 432 с.
  4. Национальные рекомендации ОССН, РКО и РНМОТ по диагностике и лечению ХСН (4-й пересмотр). Сердечная недостаточность. 2013; 14 (7, 81): 379–472.
  5. Рекомендации по количественной оценке структуры и функции камер сердца. Под ред. Ю.А. Васюка. Российский кардиологический журнал. 2012; 3 (95): 28.
  6. Богданов Д.В., Эктова Л.А., Палько Н.Н. Скрытая систолическая дисфункция левого желудочка при гипертрофиях миокарда различного генеза. Актуальные вопросы медицины ХХI века. Сб. статей Междунар. науч.-практ. конф. Уфа: РИЦ БашГУ. 2014. С. 3–6.
  7. Шапошник И. И., Богданов Д. В. Гипертрофическая кардиомиопатия. М.: Медпрактика-М. 2008. 127.
  8. Prinz C., van Buuren F., Bogunovic N., Bitter T., Faber L., Horstkotte D. In patients with hypertrophic cardiomyopathy myocardial fibrosis is associated with both left ventricular and left atrial dysfunction. Acta Cardiol. 2012; 67 (2): 187–193.
  9. Kauer F., van Dalen B.M., Michels M., Soliman O.I., Vletter W.B., van Slegtenhorst M. et al. Diastolic abnormalities in normal phenotype hypertrophic cardiomyopathy gene carriers: a study using speckle tracking echocardiography. Echocardiography. 2013; 30 (5): 558–563.
  10. Dragulescu A., Mertens L., Friedberg M.K. Interpretation of left ventricular diastolic dysfunction in children with cardiomyopathy by echocardiography: problems and limitations. Circ. Cardiovasc. Imaging. 2013; 6 (2): 254–261.
  11. Maskatia S.A., Decker J.A., Spinner J.A. Kim J.J., Price J.F., Jefferies J.L. et al. Restrictive physiology is associated with poor outcomes in children with hypertrophic cardiomyopathy. Pediatr. Cardiol. 2012; 33: 141–149.
  12. Караулова Ю.А., Павлова А.В., Моисеев В.С. Изучение клинико-генетических детерминант гипертрофии левого желудочка у больных артериальной гипертонией и гипертрофической кардиомиопатией. Практикующий врач. 2006; 1: 5.
  13. Pinamonti B., Merlo M., Nangah R., Korcova R., Di Lenarda A., Barbati G. et al. The progression of left ventricular systolic and diastolic dysfunctions in hypertrophic cardiomyopathy: clinical and prognostic significance. J. Cardiovasc. Med. 2010; 11 (9): 669–677.
  14. CiampiQ., Betocchi S., Losi M.A., Lombardi R., Villari B., Chiariello M.Effect of hypertrophy on left ventricular diastolic function in patientswith hypertrophic cardiomyopathy. Heart Int. 2006; 2 (2): 106.
  15. van Heerebeek L., Borbély A., Niessen H.W., Bronzwaer J.G., van der Velden J., Stienen G.J. et al. Myocardial structure and function differ in systolic and diastolic heart failure. Circulation. 2006; 113 (16): 1966–1973.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 1970 "Paediatrician" Publishers LLC



This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies